Paul Scholl

3.6k total citations · 1 hit paper
38 papers, 2.4k citations indexed

About

Paul Scholl is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Scholl has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Scholl's work include T-cell and B-cell Immunology (12 papers), Toxin Mechanisms and Immunotoxins (11 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Paul Scholl is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Toxin Mechanisms and Immunotoxins (11 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Paul Scholl collaborates with scholars based in United States, France and Canada. Paul Scholl's co-authors include Raif S. Geha, Talal A. Chatila, Sudha Visvanathan, R S Geha, Steven J. Padula, R S Geha, Mary Ellen Conley, Hans D. Ochs, E. Richard Stiehm and Jerry A. Winkelstein and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul Scholl

38 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

2017 392 citations James G. Krueger, Alan Menter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Scholl United States	19	1.9k	354	339	315	293	38	2.4k
Joyce Eskdale United Kingdom	26	1.8k 1.0×	187 0.5×	490 1.4×	181 0.6×	452 1.5×	46	3.0k
Ikuya Tsuge Japan	24	1.6k 0.8×	309 0.9×	199 0.6×	266 0.8×	290 1.0×	87	3.0k
Fabio Almerigogna Italy	23	1.8k 1.0×	230 0.6×	187 0.6×	118 0.4×	364 1.2×	61	2.9k
J. Alero Thomas United Kingdom	29	1.2k 0.6×	172 0.5×	150 0.4×	211 0.7×	440 1.5×	57	3.0k
E Hermann Germany	19	1.2k 0.6×	255 0.7×	542 1.6×	177 0.6×	503 1.7×	48	2.3k
Verónica García Argentina	25	1.9k 1.0×	304 0.9×	257 0.8×	189 0.6×	402 1.4×	70	2.9k
Christiane Pfeiffer Germany	22	1.4k 0.7×	362 1.0×	521 1.5×	64 0.2×	370 1.3×	39	2.5k
Xavier Paliard United States	22	1.7k 0.9×	135 0.4×	191 0.6×	64 0.2×	360 1.2×	33	2.6k
L S Rott United States	13	1.4k 0.7×	293 0.8×	57 0.2×	300 1.0×	424 1.4×	14	2.3k
Weitao Huang United States	13	2.0k 1.1×	309 0.9×	171 0.5×	147 0.5×	286 1.0×	16	2.7k

Countries citing papers authored by Paul Scholl

Since Specialization

Citations

This map shows the geographic impact of Paul Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Scholl more than expected).

Fields of papers citing papers by Paul Scholl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Scholl. The network helps show where Paul Scholl may publish in the future.

Co-authorship network of co-authors of Paul Scholl

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Scholl. A scholar is included among the top collaborators of Paul Scholl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Scholl. Paul Scholl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baeten, Dominique, Mikkel Østergaard, James Cheng‐Chung Wei, et al.. (2018). Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Annals of the Rheumatic Diseases. 77(9). 1295–1302. 279 indexed citations

Krueger, James G., Laura K. Ferris, Alan Menter, et al.. (2015). Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 136(1). 116–124.e7. 194 indexed citations

Huang, Fenglei, Paul Scholl, David B. Huang, et al.. (2010). Coadministration With Lopinavir and Ritonavir Decreases Exposure to BILR 355, a Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(7). 1061–1070. 2 indexed citations

Park, Seo Young, Yufeng Liu, Dacheng Liu, & Paul Scholl. (2010). Multicategory composite least squares classifiers. Statistical Analysis and Data Mining The ASA Data Science Journal. 3(4). 272–286. 2 indexed citations

Winkelstein, Jerry A., Hans D. Ochs, Paul Scholl, et al.. (2003). The X-Linked Hyper-IgM Syndrome. Medicine. 82(6). 373–384. 317 indexed citations

Lobo, Francis M., Paul Scholl, & Ramsay Fuleihan. (2002). CD40 Ligand-Deficient T Cells from X-Linked Hyper-IgM Syndrome Carriers Have Intrinsic Priming Capability. The Journal of Immunology. 168(3). 1473–1478. 10 indexed citations

Scholl, Paul, et al.. (1998). Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome. Journal of the American Academy of Dermatology. 38(2). 191–196. 15 indexed citations

O’Gorman, Maurice R.G., et al.. (1997). Development of a Rapid Whole Blood Flow Cytometry Procedure for the Diagnosis of X-Linked Hyper-IgM Syndrome Patients and Carriers. Clinical Immunology and Immunopathology. 85(2). 172–181. 42 indexed citations

Tsitsikov, Erdyni N., et al.. (1995). Cross-linking of Fc receptors activates HIV-1 long terminal repeat-driven transcription in human monocytes. International Immunology. 7(10). 1665–1670. 16 indexed citations

10.

Scholl, Paul & Raif S. Geha. (1994). MHC class II signaling in B-cell activation. Immunology Today. 15(9). 418–422. 83 indexed citations

11.

Scholl, Paul, et al.. (1994). Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn.. The Journal of Experimental Medicine. 180(3). 1165–1170. 125 indexed citations

12.

Scholl, Paul, David G. Ahern, & Raif S. Geha. (1992). Protein tyrosine phosphorylation induced via the IgG receptors Fc gamma Ri and Fc gamma RII in the human monocytic cell line THP-1. The Journal of Immunology. 149(5). 1751–1757. 65 indexed citations

13.

Ramesh, N, François Spertini, Paul Scholl, & Raif S. Geha. (1992). A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles. The Journal of Immunology. 148(4). 1025–1030. 6 indexed citations

14.

Sékaly, Rafick‐Pierre, G Croteau, Michael Bowman, et al.. (1991). The CD4 molecule is not always required for the T cell response to bacterial enterotoxins.. The Journal of Experimental Medicine. 173(2). 367–371. 17 indexed citations

15.

Chatila, Talal A., Paul Scholl, François Spertini, et al.. (1991). Toxic Shock Syndrome Toxin-1, Toxic Shock, and the Immune System. Current topics in microbiology and immunology. 174. 63–79. 9 indexed citations

16.

Scholl, Paul, et al.. (1990). Binding of toxic shock syndrome toxin‐1 to murine major histocompatibility complex class II molecules. European Journal of Immunology. 20(9). 1911–1916. 33 indexed citations

17.

Scholl, Paul, et al.. (1990). Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.. The Journal of Immunology. 144(1). 226–230. 96 indexed citations

18.

Karp, David R., et al.. (1990). The α1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature. 346(6283). 474–476. 93 indexed citations

19.

Mourad, Walid, Paul Scholl, Anthony Diaz, R S Geha, & Talal A. Chatila. (1989). The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.. The Journal of Experimental Medicine. 170(6). 2011–2022. 88 indexed citations

20.

Scholl, Paul, et al.. (1987). Media Attitudes of Teachers Can Be Changed.. Educational Technology archive. 27(1). 23–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact